Hydrogen sulfide as a potential therapy for heart failure—past, present, and future KB LaPenna, DJ Polhemus, JE Doiron, HA Hidalgo, Z Li, DJ Lefer Antioxidants 10 (3), 485, 2021 | 28 | 2021 |
Evaluation of 1, 2, 3‐Triazoles as Amide Bioisosteres In Cystic Fibrosis Transmembrane Conductance Regulator Modulators VX‐770 and VX‐809 JE Doiron, CA Le, BK Ody, JB Brace, SJ Post, NL Thacker, HM Hill, ... Chemistry–A European Journal 25 (14), 3662-3674, 2019 | 28 | 2019 |
Combination sodium nitrite and hydralazine therapy attenuates heart failure with preserved ejection fraction severity in a “2‐Hit” Murine Model KB LaPenna, Z Li, JE Doiron, TE Sharp III, H Xia, K Moles, K Koul, ... Journal of the American Heart Association 12 (4), e028480, 2023 | 14 | 2023 |
Structural Consequences of the 1, 2, 3‐Triazole as an Amide Bioisostere in Analogues of the Cystic Fibrosis Drugs VX‐809 and VX‐770 JE Doiron, CA Le, J Bacsa, GW Breton, KL Martin, SG Aller, M Turlington ChemMedChem 15 (18), 1720-1730, 2020 | 12 | 2020 |
Early renal denervation attenuates cardiac dysfunction in heart failure with preserved ejection fraction JE Doiron, Z Li, X Yu, KB LaPenna, H Quiriarte, TD Allerton, K Koul, ... Journal of the American Heart Association 13 (4), e032646, 2024 | 7 | 2024 |
Leveraging Adipocyte-Cardiomyocyte Signaling to Treat Ischemic Heart Failure JE Doiron, DJ Lefer Circulation Research 131 (2), 165-167, 2022 | 2 | 2022 |
Common heart failure with preserved ejection fraction animal models yield disparate myofibril mechanics AJ Fenwick, VP Jani, DB Foster, TE Sharp, TT Goodchild, K LaPenna, ... Journal of the American Heart Association 13 (2), e032037, 2024 | 1 | 2024 |
Nitric Oxide Therapy Attenuates Heart Failure with Preserved Ejection Fraction K Koul, K LaPenna, Z Li, J Doiron, J Wang, TE Sharp III, DJ Lefer The FASEB Journal 36, 2022 | 1 | 2022 |
Exercise Therapy Rescues Skeletal Muscle Dysfunction and Exercise Intolerance in Cardiometabolic HFpEF H Quiriarte, RC Noland, JE Stampley, G Davis, Z Li, E Cho, Y Kim, ... JACC: Basic to Translational Science, 2024 | | 2024 |
Adjunctive therapy with an oral H2S donor provides additional therapeutic benefit beyond SGLT2 inhibition in cardiometabolic heart failure with preserved ejection … JE Doiron, H Xia, X Yu, AR Nevins, KB LaPenna, TE Sharp III, ... British Journal of Pharmacology, 2024 | | 2024 |
Reduced Hydrogen Sulfide Bioavailability Contributes to Cardiometabolic Heart Failure with Preserved Ejection Fraction J Doiron, M Elbatreek, H Xia, X Yu, WHW Tang, K LaPenna, T Sharp, ... bioRxiv, 2024.09. 16.613349, 2024 | | 2024 |
Hydrogen Sulfide Dysregulation in Heart Failure With Preserved Ejection Fraction JER Doiron Louisiana State University Health Sciences Center, 2024 | | 2024 |
Abstract P1024: Cardiomyocyte Mechanics In Animal Models Of Heart Failure With Preserved Ejection Fraction V Jani, A Fenwick, S Mishra, TE Sharp, J Doiron, KB LaPenna, ... Circulation Research 133 (Suppl_1), AP1024-AP1024, 2023 | | 2023 |
364 Beneficial Actions of SGLT2 Inhibition and H2S Therapy in Heart Failure with Preserved Ejection Fraction J Doiron, Z Li, H Xia, KB Lapenna, TD Allerton, DR Kapusta, DJ Lefer Journal of Clinical and Translational Science 7 (s1), 108-108, 2023 | | 2023 |
Overexpression of endothelial cell Cystathionine Gamma Lyase preserves cardiovascular function in heart failure with preserved ejection fraction H Xia, Z Li, K LaPenna, J Doiron, T Sharp III, K Moles, J Elrod, ... Journal of Molecular and Cellular Cardiology 173, S130, 2022 | | 2022 |
H2S Therapy Improves Diastolic Dysfunction and Exercise Capacity in Two‐Hit Murine Model of Heart Failure with Preserved Ejection Fraction JE Doiron, K Lapenna, Z Li, H Xia, T Goodchild, M Xian, J Kang, D Lefer The FASEB Journal 36, 2022 | | 2022 |
Role of S‐nitrosoglutathione reductase (GSNOR) Dysregulation and Nitrosative Stress in Heart Failure With Preserved Ejection Fraction KB LaPenna, Z Li, TE Sharp, KH Mose, JE Doiron, H Xia, TT Goodchild, ... The FASEB Journal 36, 2022 | | 2022 |
Combination Therapy with Sodium Nitrite and Hydralazine Attenuates Oxidative Stress in Heart Failure with Preserved Ejection Fraction K Koul, K Lapenna, Z Li, J Doiron, J Wang, TE Sharp III, DJ Lefer | | 2021 |
Pharmacological analysis of 1, 2, 3-triazoles as amide bioisosteres in potentiators of the cystic fibrosis transmembrane conductance regulator protein J Doiron, G Breton, L Tang, W Wang, S Rowe, S Aller, M Turlington ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 257, 2019 | | 2019 |